Resources

Impact of EU MDR 2017/745 on Medical Device Labeling

The EU Medical Devices Regulation (EU MDR Regulation) replaced the Medical Device Directive (MDD) and introduced stricter medical device labeling rules to ensure better transparency, quality, and patient safety in line with global standards. Manufacturers must comply with these updated regulations to market medical devices in the EU. Labeling is critical for safe device use; and symbols are used to communicate essential information on the device label to ensure proper handling and adherence to regulatory standards. The regulation requires all devices to include a Unique Device Identification (UDI) to improve traceability and support post-market surveillance, as outlined in Chapter III, Annex [...]

Impact of EU MDR 2017/745 on Medical Device Labeling2026-10-27T08:02:17+00:00

Clinical Evaluation and Labelling: How They Are Interlinked

How Clinical Evaluation and Labelling Work Together Clinical evaluation and labelling form two integral components of the regulatory framework under the European Union Medical Device Regulation (MDR) 2017/745. Though quite distinct, these two processes are intricately related and perform complementary functions for compliance with the requirements imposed by the GSPRs contained in Annex I of the MDR. Multiple guidance documents issued by the Medical Device Coordination Group (MDCG) provide detailed insights into this interdependence: MDCG 2020–13 emphasizes the importance of taking all necessary steps to ensure that medical devices are safe, effective, and compliant with regulatory requirements. MDCG 2021–24 explains how [...]

Clinical Evaluation and Labelling: How They Are Interlinked2026-10-27T07:00:46+00:00

Clinical Evaluation Process For Combination Products

Navigating Clinical Evaluation Process for Combination Products! Combination products are a niche class of medical devices whereby two or more regulated constituents, such as drugs and devices are combined to achieve a specific therapeutic purpose. These products necessarily require careful consideration of pharmaceutical and medical device regulations that ensure compliance and demonstrate both safety, performance as well as clinical benefit. This article details the step-by-step approach and considerations that guide the Clinical Evaluation Process in the context of combination products that fall under the EU’s Medical Device Regulation 2017/745. What Are Combination Devices? Combination devices are products that either: 1. Incorporate [...]

Clinical Evaluation Process For Combination Products2026-10-28T08:43:28+00:00

Demonstrating Equivalence Aspects

Understanding The Technical, Biological, And Clinical Aspects Of Demonstrating Equivalence The MDR (Annex XIV, Part A) emphasizes the importance of considering technical, biological, and clinical characteristics when demonstrating equivalence to other devices. The demonstration of equivalence must adhere to the requirements outlined in Part A, section 3 of Annex XIV of EU-MDR. Annex XIV part A requires that the manufacturer should demonstrate that there are no clinically significant differences in safety or clinical performance with regard to technical, biological and clinical characteristics. MEDDEV 2.7/1 Rev. 4 is a guidance document that provides guidance on clinical evaluation in the European Union. However, because [...]

Demonstrating Equivalence Aspects2026-10-29T08:20:37+00:00

Successful Clinical Evaluation Report under MDR 2017/745

Key Components of a Successful Clinical Evaluation Report under MDR 2017/745 A Clinical Evaluation Report (CER) becomes an essential document in terms of safety and performance of the device to prove that a device is safe and performs as intended. These are the key components of a successful CER within the framework of MDR 2017/745. Scope and Objectives The first and foremost stage in the preparation of the Clinical evaluation report includes and emphasizes the clear definition of its respective scope and objectives. Aspects of this include defining the description of the device, of its intended purpose. This must include risk classification [...]

Successful Clinical Evaluation Report under MDR 2017/7452026-10-27T07:02:11+00:00

Clinical Evaluation of Reusable, Measuring & Sterile Class I Medical Devices

Clinical Evaluation of Reusable, Measuring & Sterile Class I Medical Devices Class I medical devices under the EU MDR are considered low-risk devices. These medical devices are usually non-invasive and for transient use, such as hospital beds or bandages, or invasive tools used only transiently in body orifices, such as dental impression materials. Class I medical devices can be active, such as examination lamps. However, the MDCG 2021–24 Guidance on the classification of medical devices specifies three subclasses of Class I devices based on device-specific features, that do require assessment by a Notified Body. Class I medical devices are subdivided: Class Ir (Reusable [...]

Clinical Evaluation of Reusable, Measuring & Sterile Class I Medical Devices2026-10-28T08:43:27+00:00

Components of a PMCF Plan

Key Components of a PMCF Plan According to the European Union Medical Devices Regulation (EU) 2017/745, every manufacturer of medical devices must carry out periodic post-market clinical follow-up (PMCF) evaluations and collect and submit well-structured post-market surveillance reports regularly. It is a proactive process that collects and evaluates clinical data on the safety and performance of a medical device in normal use. According to the MDR Annex XIV Part B, PMCF should run continuously throughout the entire lifetime of a device. A PMCF Plan is required by the European Union Medical Device Regulation (MDR 2017/745) for Class IIa, IIb, and [...]

Components of a PMCF Plan2026-10-28T08:43:29+00:00
Go to Top